Draft Recommendation Statement
Speech and Language Delay and Disorders in Children Age 5 and Younger: Screening
This opportunity for public comment expired on December 15, 2014 at 5:00 PM EST
Note: This is a Draft Recommendation Statement. This draft is distributed solely for the purpose of receiving public input. It has not been disseminated otherwise by the USPSTF. The final Recommendation Statement will be developed after careful consideration of the feedback received and will include both the Research Plan and Evidence Review as a basis.
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Draft: Recommendation Summary
|Children Age 5 Years or Younger|
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for speech and language delay and disorders in children age 5 years or younger.
See the Clinical Considerations section for suggestions for practice regarding the I statement.
The USPSTF makes recommendations about the effectiveness of specific preventive care services for patients without related signs or symptoms.
It bases its recommendations on the evidence of both the benefits and harms of the service, and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment.
The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decisionmaking to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms.
Children with speech and language delays develop speech or language in the correct sequence but at a slower rate than expected, while children with speech and language disorders develop speech or language that is qualitatively different from typical development. Differentiating between delays and disorders can be complicated. First, screening instruments have difficulty distinguishing between the two. Second, while the majority of school-age children with language disorders present with language delays as toddlers, some children outgrow their language delay.1
Information about the prevalence of speech and language delays and disorders in young children in the United States is limited. In 2007, about 2.6% of children ages 3 to 5 years received services for speech and language disabilities under the Individuals With Disabilities Education Act (IDEA).2 In one population-based study of 8-year-olds in Utah, the prevalence of children with communication disorders (speech or language), based on special education or International Classification of Disease-9 classifications, was 63.4 cases per 1,000 children.3 The prevalence of isolated communication disorders (i.e., those without a concomitant diagnosis of autism spectrum disorder or intellectual disability) was 59.1 cases per 1,000 children.
Information on the natural history of speech and language delays and disorders, including how outcomes may change as a result of screening or treatment, is also limited.
The USPSTF found inadequate evidence on the accuracy of screening instruments for speech and language delay for use in primary care. The USPSTF also found inadequate evidence on the accuracy of surveillance (active monitoring) by primary care clinicians to identify children for further evaluation for speech and language delays and disorders.
Benefits of Early Detection and Intervention
The USPSTF found inadequate evidence on the benefits of screening and early intervention for speech and language delay and disorders.
The USPSTF found inadequate evidence on the effectiveness of screening for speech and language delay and disorders on improving speech, language, or other outcomes. Although the USPSTF found evidence that interventions improve some measures of speech and language for some children, there is inadequate evidence on the effectiveness of interventions in screen-detected children in a primary care setting.
The USPSTF found inadequate evidence on the effectiveness of interventions for speech and language delay and disorders on outcomes not specific to speech (e.g., academic achievement, behavioral competence, socioemotional development, and quality of life).
Harms of Early Detection and Intervention
The USPSTF found inadequate evidence on the harms of screening and interventions for speech and language delay and disorders in children age 5 years or younger.
The USPSTF concludes that the evidence is insufficient, and that the balance of benefits and harms of screening and interventions for speech and language delay and disorders in young children in primary care settings cannot be determined.
Draft: Clinical Considerations
Patient Population Under Consideration
This recommendation applies to children age 5 years or younger who have not already been diagnosed with a speech and language disorder, other developmental disorder, or hearing impairment.
Suggestions for Practice Regarding the I Statement
Potential Preventable Burden
Information about the prevalence of speech and language delays and disorders in young children in the United States is limited. In 2007, about 2.6% of children ages 3 to 5 years received services for speech and language disabilities under IDEA.2
Childhood speech and language disorders include a broad set of disorders with heterogeneous outcomes. Information about the natural history of these disorders is limited, as most affected children receive at least some type of intervention. However, there is some evidence that young children with speech and language delay may be at increased risk for language-based learning disabilities.4
The potential harms of screening and interventions for speech and language disorders in young children in primary care include the time, effort, and anxiety associated with further testing after a positive screen, as well as the potential detriments associated with diagnostic labeling. However, the USPSTF found no studies on these harms.
Surveillance or screening for speech and language disorders in the clinical setting is commonly recommended as part of routine developmental surveillance and screening in primary care (i.e., during well-child visits).5 In practice, however, such screening is not universal. The previous evidence review6 found that 55% of parents reported that their toddler did not receive any type of developmental assessment at their well-child visit, and 30% of parents reported that their child’s health care provider had not discussed with them how their child communicates.7 In a 2009 study, approximately half of responding pediatricians reported that they “always or almost always” use a standardized screening tool to detect developmental problems in young children; about 40% of respondents reported using the Ages and Stages Questionnaire (ASQ).8
Assessment of Risk
Based on a review of 31 cohort studies, several risk factors have been reported to be associated with speech and language delay and disorders, including male sex, family history of speech and language impairment, low parental education level, and perinatal risk factors (e.g., prematurity, low birth weight, and birth difficulties).9
The USPSTF found inadequate evidence on specific screening tests for use in primary care. Screening tests that are widely used in the United States include the ASQ, the Language Development Survey (LDS), and the MacArthur-Bates Communicative Development Inventory (CDI).
Interventions for childhood speech and language disorders vary widely and can include speech-language therapy sessions and assistive technology (if indicated).
Interventions are commonly individualized to each child's specific pattern of symptoms, needs, interests, personality, and learning style. Treatment plans also incorporate the priorities of the child, parents, and/or teachers. Speech-language therapy may take place in various settings, such as speech and language specialty clinics, the school or classroom, and the home. Therapy may be administered on an individual basis and/or in groups, and may be child-centered and/or include peer and family components. Therapists may be speech-language pathologists, educators, or parents. The duration and intensity of the intervention depends on the severity of the speech or language disorder and the child's progress in meeting therapy goals.
Other Approaches to Prevention
The USPSTF recommends screening for hearing loss in all newborn infants (B recommendation). The USPSTF is developing a recommendation on screening for autism spectrum disorders in young children. These recommendations are available on the USPSTF Web site (www.uspreventiveservicestaskforce.org).
All states have designated programs that offer evaluation and intervention services to children ages 0 to 5 years. IDEA is a law that ensures early intervention, special education, and related services for children with disabilities in the United States. Infants and toddlers with disabilities (birth to age 2 years) and their families may receive early intervention services under IDEA Part C, while children and adolescents (ages 3 to 21 years) may receive special education and related services under IDEA Part B.10
Draft: Other Considerations
Research Needs and Gaps
The USPSTF identified several evidence gaps, including a critical need for studies specifically designed and executed to address whether systematic, routine screening for speech and language delay and disorders in young children in primary care settings leads to improved speech, language, or other outcomes. Studies on the feasibility of speech- and language-specific screening as part of routine developmental screening and that identify the most effective screening instruments are needed. Studies on the potential harms of screening and interventions are also needed.
Information about the prevalence of speech and language delays and disorders in young children in the United States is relatively lacking. Although some risk factors have been reported to be associated with speech and language delay and disorders, there is little information about which patient characteristics can be used for risk stratification or assessment. More information about the specific factors associated with intervention effectiveness, including the potential effects of age at diagnosis, age at treatment, treatment type, and treatment duration, is needed.
Burden of Disease
According to the American Speech-Language-Hearing Association, speech sound disorders affect 10% of children. The estimated prevalence of language difficulty in preschool-age children is between 2% and 19%. Specific language impairment is one of the most common childhood disorders, affecting 7% of children. More than 2 million Americans stutter, half of whom are children.11
Childhood speech and language disorders include a broad set of disorders with heterogeneous outcomes. Young children with speech and language delay may be at increased risk for learning disabilities once they reach school age.4 Children with speech sound disorders or language impairment are at greatest risk for being diagnosed with a literacy disability,12 including difficulty with reading in grade school13-16 and/or with written language.17
The risk for poor outcomes is greater for children whose disorders persist past the early childhood years and for those who have lower IQ scores and language impairments rather than only speech impairments.18 Children who are diagnosed with language delays may have more problems with behavior and psychosocial adjustment, which may persist into adulthood.19, 20
Scope of Review
To update its 2006 recommendation statement, the USPSTF commissioned a systematic evidence review on screening for speech and language delay and disorders in children age 5 years or younger. The USPSTF reviewed the evidence on the accuracy of screening in primary care settings, as well as the role of surveillance (active monitoring) by primary care clinicians to identify children for further diagnostic evaluation and interventions for speech and language delay and disorders. The USPSTF also evaluated evidence on whether screening and interventions for speech and language delay and disorders lead to improved speech, language, or other outcomes, as well as the potential harms associated with screening and interventions.
The evidence review focused on speech and language delays and disorders with a “primary” or developmental etiology. In other words, the review was limited to children who had not been previously identified with another disorder or disability that may cause speech or language impairment. The review excluded studies that focused on acquired, focal causes of speech and language delay.
The evidence review focused on studies conducted in children age 5 years or younger in which any child who screened positive received formal diagnostic assessment for speech and language delays and disorders by 6 years of age. Studies of treatment and/or intervention outcomes were not restricted by age at treatment, but focused primarily on toddlers and preschool-age children.
The evidence review included randomized, controlled trials and other systematic reviews, as well as cohort studies of screening and surveillance for speech and language delay and disorders. The USPSTF focused on screening instruments specific to speech and language conditions, as well as more general developmental screening tools with speech and language modules. All tools needed to be feasible for use in primary care, or results had to be interpretable within a primary care setting. For surveillance studies, the USPSTF considered processes of monitoring speech and language in primary care settings rather than formal screening instruments.
Included screening and surveillance studies had to be conducted, or results had to be interpretable, in primary care settings. In contrast, included treatment studies were not limited by study setting, which included speech and language clinics, schools, and/or home settings.
The current review differed somewhat from the previous review in that it focused on screening tools that can be administered within the usual length of a primary care visit (≤10 minutes) or tools that require more than 10 minutes outside of a primary care setting if the results can be readily interpreted by a primary care clinician. The current review also focused more on studies of patients without known causes of speech and language delay (as these are the patients most likely to be identified through screening).
Accuracy of Screening Tests
The USPSTF identified 24 studies (five good- and 19 fair-quality)9 that evaluated the accuracy of 20 different screening tools. The majority of studies included 2- and 3-year-olds, but the ages varied. Recruitment techniques and venues included advertisements, birth registries, early childhood programs, university research programs, medical practices, and school registration and entrance medical examinations.
The USPSTF considered seven parent-administered screening tools: the ASQ; General Language Screen (formerly known as the Parent Language Checklist); Infant-Toddler Checklist; LDS; CDI; Speech and Language Parent Questionnaire; and the Ward Infant Language Screening Test, Assessment, Acceleration, and Remediation. The USPSTF considered 13 screening tools administered by professionals or paraprofessionals: the Battelle Developmental Inventory, BRIGANCE Preschool Screen, Davis Observation Checklist for Texas, Denver Articulation Screening Exam, DENVER II (formerly the Denver Developmental Screening Test), a standard developmental screen administered by nurses, Early Screening Profiles, Fluharty Preschool Speech and Language Screening Test, Northwestern Syntax Screening Test, Screening Kit of Language Development, Sentence Repetition Screening Test, Structured Screening Test (formerly known as the Hackney Early Language Screening Test), and Rigby’s trial speech screening test.
Test performance characteristics varied widely. Parent-administered screening tools generally performed better than other tools. Among parent-administered tools, sensitivity was generally higher for the CDI, Infant-Toddler Checklist, and LDS. Specificity was comparable across the CDI, LDS, and ASQ.
The applicability of the evidence to screening in primary care is limited by several factors. Most studies focused on prescreened populations with relatively high prevalence of language delays and disabilities (usually >10%). The USPSTF found it difficult to compare the performance of individual screening tools across different populations because different studies used different tools and outcome measures in different populations and settings. Included studies used well-regarded instruments used by speech and language pathologists as reference standards; however, different studies used different reference standards. In addition to small sample sizes, some studies were conducted in countries with health care systems that are not comparable with that of the United States.
The USPSTF identified no studies on the accuracy of surveillance of speech and language development by primary care clinicians.
Effectiveness of Early Detection and Interventions
The USPSTF identified one poor-quality randomized, controlled trial of screening for language delays in children ages 18 and 24 months that followed outcomes at ages 3 and 8 years.21 This cluster-randomized trial and followup study was conducted in 9,419 children at 55 child health centers in six geographic regions of The Netherlands. Outcomes included the percentage of children who attended a special school, percentage who repeated a class because of language problems, and percentage who scored low on standardized language tests. The authors concluded that screening toddlers for language delay reduces requirements for special education and leads to improved language performance at age 8 years. The study was rated as poor quality because of several limitations, including suboptimal rates of screening and low retention of trial subjects; reliance on indirect measures of speech and language outcomes in school-age children (instead of individualized testing); lack of blinding to screening or treatment status by teachers and parents who assessed outcomes; and lack of adjustment for other potential reasons for placement in special education.
The USPSTF identified 13 studies on the potential benefits of treatment interventions for children diagnosed with specific speech and language delays and disorders that reported inconsistent findings on speech and language outcomes.9 The majority of the trials reported improvements in speech and language measures. However, the applicability of this evidence to routine screening in a primary care setting is limited; many of the studies were conducted in very high-risk populations (i.e., high-prevalence populations). In addition, these studies did not report treatment effectiveness in children whose speech and language delay had actually been detected by screening; instead, the delays had often been identified as a result of parent or teacher concerns. A majority of the intervention studies were conducted outside of the United States, which could also limit the applicability of findings.
The USPSTF identified four studies that reported inconsistent findings on other outcomes, including socialization, reading comprehension, parental stress, and child well-being or attention level.
Potential Harms of Screening and Interventions
The USPSTF identified no studies on the potential harms of screening for speech and language delays and disorders, such as labeling or anxiety. The USPSTF identified two studies (one fair- and one good-quality) on the potential harms of treatment that reported inconsistent findings.9 The treatment group of one study reported reduced parental stress, while another study reported no effect on child well-being or attention level. Treatment harms were generally not measured or reported; the two included studies reported few data on a limited number of outcomes.
Estimate of Magnitude of Net Benefit
The USPSTF found inadequate evidence on the accuracy of screening or surveillance for speech and language delay and disorders in primary care settings. The USPSTF found inadequate evidence on the potential benefits of screening and treatment on speech, language, or other outcomes. The USPSTF found adequate evidence that treatment is associated with improvements in some speech and language measures, but inadequate evidence on its effectiveness in screen-detected children. The USPSTF found inadequate evidence on the association between treatment and outcomes other than speech and language. The USPSTF found inadequate evidence on the potential harms of screening and treatment for speech and language delay and disorders. Therefore, the USPSTF concludes that the evidence is insufficient and that the balance of benefits and harms of screening for speech and language delays and disorders in young children cannot be determined.
Draft: Update of Previous USPSTF Recommendation
This recommendation replaces the 2006 USPSTF recommendation on screening for speech and language delays. The current recommendation is consistent with the previous recommendation, which concluded that the evidence on the routine use of brief, formal screening instruments in primary care to detect speech and language delay in children age 5 years or younger is insufficient.
Draft: Recommendations of Others
The American Academy of Pediatrics22 recommends that developmental surveillance be incorporated at every well-child preventive care visit for children from birth through age 3 years. Any concerns raised during surveillance should be promptly addressed with standardized developmental screening tests. In addition, screening tests should be administered regularly at well-child visits at the ages of 9, 18, and 24 or 30 months.
1. Ellis EM, Thal DJ. Early language delay and risk for language impairment. Perspect Lang Learn Educ. 2008;15(3):93-100.
2. U.S. Department of Education, Office of Special Education and Rehabilitative Services, Office of Special Education Programs. 31st Annual Report to Congress on the Implementation of the Individuals With Disabilities Education Act, 2009. Washington, DC: U.S. Department of Education; 2012.
3. Pinborough-Zimmerman J, Satterfield R, Miller J, Bilder D, Hossain S, McMahon W. Communication disorders: prevalence and comorbid intellectual disability, autism, and emotional/behavioral disorders. Am J Speech Lang Pathol. 2007;16(4):359-67.
4. Bashir AS, Scavuzzo A. Children with language disorders: natural history and academic success. J Learn Disabil. 1992;25(1):53-65.
5. Hagan JF Jr, Shaw JS, Duncan P, eds. Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents. 3rd ed. Elk Grove Village, IL: American Academy of Pediatrics; 2008.
6. Nelson HD, Nygren P, Walker M, Panoscha R. Screening for speech and language delay in preschool children: systematic evidence review for the US Preventive Services Task Force. Pediatrics. 2006;117(2):e298-319.
7. Halfon N, Olson L, Inkelas M, Mistry R, Sareen H, Lange L, et al. Summary statistics from the National Survey of Early Childhood Health, 2000. Vital Health Stat 15. 2002;3:1-27.
8. Radecki L, Sand-Loud N, O’Connor KG, Sharp S, Olson LM. Trends in the use of standardized tools for developmental screening in early childhood: 2002-2009. Pediatrics. 2011;128(1):14-9.
9. Berkman ND, Wallace IF, Watson L, Coyne-Beasley T, Cullen K, Wood CT, et al. Screening for Speech and Language Delay and Disorders in Children Age 5 Years or Younger. Evidence Synthesis No. 120. AHRQ Publication No. 13-05197-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2014.
10. U.S. Department of Education. Building the Legacy: IDEA 2004. Washington, DC: U.S. Department of Education; 2014. Accessed at http://idea.ed.gov/ on 29 October 2014.
11. American Speech-Language-Hearing Association. Speech-Language Pathology Medical Review Guidelines. Rockville, MD: American Speech-Language-Hearing Association; 2011. Accessed at http://www.asha.org/practice/reimbursement/SLP-medical-review-guidelines/ on 30 October 2014.
12. Peterson RL, Pennington BF, Shriberg LD, Boada R. What influences literacy outcome in children with speech sound disorder? J Speech Lang Hear Res. 2009;52(5):1175-88.
13. Catts HW, Fey ME, Tomblin JB, Zhang X. A longitudinal investigation of reading outcomes in children with language impairments. J Speech Lang Hear Res. 2002;45(6):1142-57.
14. Scarborough HS, Dobrich W. Development of children with early language delay. J Speech Hear Res. 1990;33(1):70-83.
15. Richman N, Stevenson J, Graham PJ. Pre-School to School: A Behavioural Study. London: Academic Press; 1982.
16. Silva PA, Williams S, McGee R. A longitudinal study of children with developmental language delay at age three: later intelligence, reading and behaviour problems. Dev Med Child Neurol. 1987;29(5):630-40.
17. Bishop DV, Clarkson B. Written language as a window into residual language deficits: a study of children with persistent and residual speech and language impairments. Cortex. 2003;39(2):215-37.
18. Snowling MJ, Bishop DV, Stothard SE, Chipchase B, Kaplan C. Psychosocial outcomes at 15 years of children with a preschool history of speech-language impairment. J Child Psychol Psychiatry. 2006;47(8):759-65.
19. Law J, Rush R, Schoon I, Parsons S. Modeling developmental language difficulties from school entry into adulthood: literacy, mental health, and employment outcomes. J Speech Lang Hear Res. 2009;52(6):1401-16.
20. Cohen NJ, Menna R, Vallance DD, Barwick MA, Im N, Horodezky NB. Language, social cognitive processing, and behavioral characteristics of psychiatrically disturbed children with previously identified and unsuspected language impairments. J Child Psychol Psychiatry. 1998;39(6):853-64.
21. van Agt HM, van der Stege HA, de Ridder-Sluiter H, Verhoeven LT, de Koning HJ. A cluster-randomized trial of screening for language delay in toddlers: effects on school performance and language development at age 8. Pediatrics. 2007;120(6):1317-25.
22. Council on Children With Disabilities; Section on Developmental Behavioral Pediatrics; Bright Futures Steering Committee; Medical Home Initiatives for Children With Special Needs Project Advisory Committee. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Pediatrics. 2006;118(1):405-20.
Internet Citation: Draft Recommendation Statement: Speech and Language Delay and Disorders in Children Age 5 and Younger: Screening. U.S. Preventive Services Task Force. November 2014.